Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Toxicities experienced by the patients

From: Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer

Toxicity N (%)
Neutropenia  
Grade 1 1
Grade 2 4
Grade 3 1
Grade 4 1
Any 7 (35%)
Nausea/vomiting  
Grade 1 4
Grade 2 6
Any 10 (50%)
Anemia  
Grade 1 0
Grade 2 0
Grade 3 1
Any 1 (5%)
Neurotoxicity  
Grade 1 2
Grade 2 4
Grade 3 0
Grade 4 0
Any 6 (30%)